4//SEC Filing
Forest Laboratories, LLC 4
Accession 0001209191-14-046075
CIK 0000038074operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:14 PM ET
Size
23.7 KB
Accession
0001209191-14-046075
Insider Transaction Report
Form 4
GOODMAN KENNETH E
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−4,000→ 0 totalExercise: $39.88Exp: 2017-08-13→ Common Stock (4,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−4,000→ 0 totalExercise: $38.33Exp: 2018-08-11→ Common Stock (4,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−4,000→ 0 totalExercise: $26.25Exp: 2019-08-10→ Common Stock (4,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−5,621→ 0 totalExercise: $28.23Exp: 2020-08-08→ Common Stock (5,621 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−5,546→ 0 totalExercise: $33.43Exp: 2021-08-22→ Common Stock (5,546 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−7,815→ 0 totalExercise: $34.54Exp: 2022-08-22→ Common Stock (7,815 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-07-01−5,909→ 0 totalExercise: $42.61Exp: 2023-08-14→ Common Stock (5,909 underlying) - Disposition to Issuer
Restricted Stock
2014-07-01−2,967→ 0 total - Disposition to Issuer
Common Stock
2014-07-01−37,503→ 0 total
Footnotes (10)
- [F1]Each share of common stock was disposed of pursuant to the Merger Agreement, dated as of February 17, 2014 (the "Merger Agreement"), by and among the issuer and Actavis plc ("Actavis"), Tango US Holdings Inc., Tango Merger Sub 1 LLC, and Tango Merger Sub 2 LLC in exchange for either (A) $26.04 in cash plus 0.3306 Actavis ordinary shares having a market value of $224 per share on the effective date of the merger or (B) $25.67 in cash plus 0.332623 Actavis ordinary shares having a market value of $224 per share on the effective date of the merger, depending on the consideration election made by the reporting person and the consideration election proration procedures set forth in the Merger Agreement.
- [F10]The options are currently exercisable.
- [F2]Pursuant to the terms of the Merger Agreement, each restricted share of common stock converted as of the effective time of the transaction into the right to receive $103.43 in cash.
- [F3]The options are currently exercisable.
- [F4]Pursuant to the terms of the Merger Agreement, (a) each vested option to purchase issuer common stock was assumed by Actavis pursuant to the Merger Agreement and replaced with an option to purchase a number of whole Actavis ordinary shares equal to the product of (i) the number of shares of issuer common stock subject to such vested option multiplied by (ii) 0.4723, at an exercise price per share equal to the quotient obtained by dividing (x) the exercise price per share of such vested option by (y) 0.4723; and (b) each unvested option to purchase common stock converted as of the effective time of the transaction into the right to receive an amount in cash equal to the product of the excess, if any, of $103.43 over the exercise price per share of such unvested option multiplied by the number of shares of issuer common stock subject to such option.
- [F5]The options are currently exercisable.
- [F6]The options are currently exercisable.
- [F7]The options are currently exercisable.
- [F8]The options are currently exercisable.
- [F9]The options are currently exercisable.
Documents
Issuer
Forest Laboratories, LLC
CIK 0000038074
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000038074
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:14 PM ET
- Size
- 23.7 KB